CRISPR Therapeutics AG - NAMEN AKT (CRSP)

Q4 2018 13F Holders as of 12/31/2018

Type / Class
Equity / NAMEN AKT
Number of holders
152
Total Shares
22.1M
Shares change
-768K
Total reported value, excl. options
$631M
Value change
-$57.7M
Put/Call ratio
2.05
Number of buys
62
Number of sells
-89
Price
$28.57
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.